Cargando…
Applications for open access normalized synthesis in metastatic prostate cancer trials
Recent metastatic castration-resistant prostate cancer (mCRPC) clinical trials have integrated homologous recombination and DNA repair deficiency (HRD/DRD) biomarkers into eligibility criteria and secondary objectives. These trials led to the approval of some PARP inhibitors for mCRPC with HRD/DRD i...
Autores principales: | Luechtefeld, Thomas, Bozada, Thomas, Goel, Rahul, Wang, Lin, Paller, Channing J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511148/ https://www.ncbi.nlm.nih.gov/pubmed/36171797 http://dx.doi.org/10.3389/frai.2022.984836 |
Ejemplares similares
-
Sysrev: A FAIR Platform for Data Curation and Systematic Evidence Review
por: Bozada, Thomas, et al.
Publicado: (2021) -
NFAD: fixing anomaly detection using normalizing flows
por: Ryzhikov, Artem, et al.
Publicado: (2021) -
Attenuated and normalized item-item product network for sequential recommendation
por: Di, Weiqiang, et al.
Publicado: (2022) -
Deep Active Learning via Open-Set Recognition
por: Mandivarapu, Jaya Krishna, et al.
Publicado: (2022) -
Research agenda for algorithmic fairness studies: Access to justice lessons for interdisciplinary research
por: Kontiainen, Laura, et al.
Publicado: (2022)